Copyright
©The Author(s) 2022.
World J Transplant. Aug 18, 2022; 12(8): 231-249
Published online Aug 18, 2022. doi: 10.5500/wjt.v12.i8.231
Published online Aug 18, 2022. doi: 10.5500/wjt.v12.i8.231
Ref. | Total number of patients, n | Risk factors associated with kidney disease | Study conclusion |
Huard et al[48] | 843 | Female sex (HR = 1.34), older age (HR = 1.38/10 yr increment), catheter-related sepsis (HR = 1.58), steroid maintenance immunosuppression (HR = 1.50), graft failure (HR = 1.76), ACR (HR = 1.64), prolonged requirement for IV fluids (HR = 2.12) or TPN (HR = 1.94), and diabetes (HR = 1.54) | Cumulative incidence of severe CKD of 3.2%, 25.1%, and 54.1% 1, 5 and 10 yr after intestinal transplant; in adjusted analysis, severe CKD was associated with a significantly higher hazard of death (HR = 6.20) |
Herlenius et al[76] | 10 | In the adult patients, GFR 3 mo post transplantation had decreased to 50% of the baseline. At 1 yr, median GFR in the adult patients was reduced by 72% (n = 5). Two patients developed renal failure within the first year and required hemodialysis | |
Ueno et al[49] | 24 | Cumulative tacrolimus levels > 4500ng ng∙day/mL associated with significantly decreased creatinine clearance at 2 yr (P = 0.006) | Post-transplant mean creatinine clearance was significantly lower at 2 yr compared to baseline (49.6 mL/min/1.73 m2vs 114 mL/min/1.73 m2, P < 0.0001) |
- Citation: Swanson KJ. Kidney disease in non-kidney solid organ transplantation. World J Transplant 2022; 12(8): 231-249
- URL: https://www.wjgnet.com/2220-3230/full/v12/i8/231.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i8.231